Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-03, Stock:ABBV, The news for the past five days is as follows:
2018-04-26: NEWS1: What Analysts Recommend for Neurocrine Biosciences in April 2018.NEWS2: Notable Thursday Option Activity: MAR, GILD, ABBV.NEWS3: Notable Thursday Option Activity: MAR, GILD, ABBV.NEWS4: How AbbVie &apos;Crushed It&apos; On Hepatitis C As Fellow Drugmaker Bristol Dips.NEWS5: Health Care Sector Update for 04/26/2018: ALXN,AXSM,ABBV,BMY.NEWS6: Health Care Sector Update for 04/26/2018: ALXN,AXSM,ABBV,BMY.NEWS7: AbbVie Inc Stock Up on Strong Earnings, Guidance Update.NEWS8: AbbVie Inc Stock Up on Strong Earnings, Guidance Update.NEWS9: Abbvie Up over 6% on 1Q18 Earnings Beat, Raised Earnings Forecast.NEWS10: DaVIta (DVA) to Report Q1 Earnings: Is a Beat in Store?.NEWS11: DaVIta (DVA) to Report Q1 Earnings: Is a Beat in Store?.NEWS12: Markets Now: Dow Gains 300 Points as Market Realizes Earnings Are Really, Really Good.NEWS13: Markets Now: Dow Gains 300 Points as Market Realizes Earnings Are Really, Really Good.NEWS14: AbbVie Inc. -- Moody's: AbbVie's share repurchase acceleration credit negative.NEWS15: AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains.NEWS16: AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains.NEWS17: Health Care Sector Update for 04/26/2018: ABBV,AXSM.NEWS18: Health Care Sector Update for 04/26/2018: ABBV,AXSM.NEWS19: There are a lot of 'table-pounding buys' in the market now: Value investor David Katz.NEWS20: DaVIta (DVA) to Report Q1 Earnings: Is a Beat in Store?.NEWS21: Is a Beat in the Cards for Gilead (GILD) in Q1 Earnings?.NEWS22: Is a Beat in the Cards for Gilead (GILD) in Q1 Earnings?.NEWS23: AbbVie Breaks Above 200-Day Moving Average - Bullish for ABBV.NEWS24: AbbVie Breaks Above 200-Day Moving Average - Bullish for ABBV.NEWS25: A Look At The Intrinsic Value Of AbbVie Inc (NYSE:ABBV).NEWS26: AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains.NEWS27: AbbVie Inc Stock Up on Strong Earnings, Guidance Update.NEWS28: Is a Beat in the Cards for Gilead (GILD) in Q1 Earnings?.NEWS29: Sales Of AbbVie's Hepatitis C Drugs Soar.NEWS30: AbbVie (ABBV) Tops Q1 Earnings and Revenues, View Up.NEWS31: AbbVie (ABBV) Tops Q1 Earnings and Revenues, View Up.NEWS32: Drug Makers: A Dose of Robust Earnings.NEWS33: Analyst Recommendations for Biogen in April.NEWS34: AbbVie (ABBV) Tops Q1 Earnings and Revenues, View Up.NEWS35: [$$] AbbVie unveils $7.5bn share buyback.NEWS36: How AbbVie &apos;Crushed It&apos; On Hepatitis C As Fellow Drugmaker Bristol Dips.NEWS37: AbbVie, Bristol-Myers Top Earnings Views, But Bristol Sales Missed.NEWS38: AbbVie: 1Q Earnings Snapshot.NEWS39: AbbVie shares rise 3% on Q1 profit, revenue beats and $7.5 billion share buyback.NEWS40: AbbVie beats quarterly revenue estimates, raises earnings forecast.NEWS41: AbbVie Reports First-Quarter 2018 Financial Results.NEWS42: Earnings Reaction History: AbbVie Inc., 54.5% Follow-Through Indicator, 4.4% Sensitive.NEWS43: Earnings Reaction History: AbbVie Inc., 54.5% Follow-Through Indicator, 4.4% Sensitive.
2018-04-27: NEWS1: 9 Highest-Yielding Dividend Aristocrats to Buy Today.NEWS2: 9 Highest-Yielding Dividend Aristocrats to Buy Today.NEWS3: HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates?.NEWS4: HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates?.NEWS5: 3 Things You Need to Know About AbbVie's Monster Q1 Earnings.NEWS6: 3 Things You Need to Know About AbbVie's Monster Q1 Earnings.NEWS7: 3 Things You Need to Know About AbbVie&apos;s Monster Q1 Earnings.NEWS8: AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting.NEWS9: AbbVie Presents New Investigational Data For Elagolix.NEWS10: AbbVie Presents New Investigational Data For Elagolix.NEWS11: Edited Transcript of ABBV earnings conference call or presentation 26-Apr-18 1:00pm GMT.
2018-04-30: NEWS1: The Good and the Bad News With Biogen Inc Earnings Results.NEWS2: The Good and the Bad News With Biogen Inc Earnings Results.NEWS3: Gilead (GILD) 1st Quarter Earnings: What to Expect.NEWS4: Gilead (GILD) 1st Quarter Earnings: What to Expect.NEWS5: Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More.NEWS6: Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More.NEWS7: AbbVie and Rice University establish K.C. Nicolaou Research Accelerator to advance therapies in oncology.NEWS8: Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More.NEWS9: Eliquis and Xeljanz: Key Growth Drivers for Pfizer in 2018.
2018-05-01: NEWS1: Why Nutrisystem, Tenet Healthcare, and AbbVie Jumped Today.NEWS2: Why Nutrisystem, Tenet Healthcare, and AbbVie Jumped Today.NEWS3: Seagate, Pfizer and Cummins skid while AbbVie jumps.NEWS4: Why Nutrisystem, Tenet Healthcare, and AbbVie Jumped Today.NEWS5: AbbVie’s Hepatitis C Franchise, Kaletra, and Synagis in 1Q18.NEWS6: MARKETS: Stocks are selling off on the ISM miss, which also reveals problems in the factory sector.NEWS7: AbbVie’s Humira and Imbruvica: 1Q18 Performance.NEWS8: How AbbVie Fared in 1Q18.NEWS9: How AbbVie Makes its Money.NEWS10: Pre-Market Most Active for May 1, 2018 :  BP, TVIX, QQQ, SNE, SHOP, AAPL, ABBV, UAA, KLXI, UA, AVXS, SQQQ.NEWS11: Pre-Market Most Active for May 1, 2018 :  BP, TVIX, QQQ, SNE, SHOP, AAPL, ABBV, UAA, KLXI, UA, AVXS, SQQQ.NEWS12: AbbVie Submits Marketing Authorization Application to the European Medicines Agency for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis.NEWS13: AbbVie Commences Self-Tender Offer for Up to $7.5 Billion of its Common Stock.NEWS14: [$$] Gilead shares rattled by sharp slide in hepatitis C drug sales.
2018-05-02: NEWS1: Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much.NEWS2: Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much.NEWS3: &quot;Fast Money&quot; final trades: SNAP, SPOT and more.NEWS4: Top 4 Marijuana Stocks to Watch.NEWS5: 9 Winning Stocks as the Bull Loses Steam.NEWS6: Gilead (GILD) Q1 Earnings & Sales Miss Estimates on Weak HCV.NEWS7: Gilead (GILD) Q1 Earnings & Sales Miss Estimates on Weak HCV.NEWS8: Analyst Recommendations for AbbVie in April.NEWS9: AbbVie to Present at the 2018 Bank of America Merrill Lynch Health Care Conference.NEWS10: Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV).NEWS11: Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV).NEWS12: Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV).NEWS13: Gilead Sciences&apos; First-Quarter Twist: Weak HIV Sales.

Answer: Decrease